Mark Cabling is an analyst at RAND Europe. In the health and wellbeing division, he works on health care innovation research and projects that involve rapid evidence assessments for clients such as Sanofi and Merck Europe, exploring the indirect burden of seasonal influenza and R&D cost transparency, respectively. He has extensive project management experience such as in a CRUK-funded project on target product profiles for oncology diagnostics. Currently, Cabling manages an evaluation of a training programme ran by the Royal College of Obstetricians and Gynecologists and the stakeholder engagement arm of a project aimed to develop an evidence centre for occupational safety and health practitioners. He also has experience in interviewing clinicians and analysing data elicited from various stakeholders, including patients, experts, and practitioners.
Before coming to RAND Europe, he was a research associate on a COVID-19 project that explored the burden of illness and health inequities suffered by ethnic minorities in the UK. He spent four years conducting applied research, first as a research assistant in breast cancer health disparities at the Lombardi Comprehensive Cancer Centre at Georgetown University’s Medical Centre, where he largely focused on the patient-clinician relationship and social support.
Cabling has 18 publications largely around the topic of breast cancer and health disparities. His expertise is in applying qualitative methods, such as interviews, rapid evidence assessments, and focus groups, to address key issues in public health. He has a Ph.D. in cancer studies from King’s College London.
Ph.D. in cancer studies, King's College London; M.A. in communication, culture and technology, Georgetown University; M.Sc. in media and communication, London School of Economics; B.A. in politics, University of Nottingham
Tagalog
